Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
SYPRIS SOLUTIONS INCSypris Solutions Reports Decline in Revenue and Profit for Q3 and Nine Months of 2025
Cardiff Lexington CorpCardiff Lexington Corporation Reports 125.6% Revenue Growth in Q3 2025
LUDWIG ENTERPRISES, INC.Ludwig Enterprises Reports Improved Net Loss but No Revenue in Q3 2025
Wintergreen Acquisition Corp.Wintergreen Acquisition Corp. Reports Profitability and Significant Asset Growth Following IPO
Circle Internet Group, Inc.Circle Internet Group Reports 66% Revenue Growth to $739.8 Million in Latest Quarter
FTC Solar, Inc.FTC Solar Reports 156.8% Revenue Growth but Incurred $23.9 Million Net Loss in Latest Quarter
GBank Financial Holdings Inc.GBank Financial Holdings Reports Q3 2025 Net Income of $4.3 Million, Loan Portfolio Grows 15%
Atara Biotherapeutics, Inc.Atara Biotherapeutics Reports Significant Revenue Decline and Workforce Reductions in Q3 2025
HARTE HANKS INCHarte Hanks Reports 17% Revenue Decline and Net Loss in Q3 2025
NUCOR CORPNucor Corporation Reports 14% Revenue Increase to $8.52 Billion in Q3 2025
SOLESENCE, INC.Solésence Reports Revenue Decline in Q3 2025, Net Loss of $1.1 Million
ENERGY FOCUS, INC/DEEnergy Focus Reports $172,000 Net Loss in Q3 2025, Revenue Declines 31%
Katapult Holdings, Inc.Katapult Holdings Reports 22.8% Revenue Growth in Q3 2025, Despite Net Loss Improvement
Connect Biopharma Holdings LtdConnect Biopharma Reports Revenue Decline and Increased Net Losses for Q3 2025
ACCESS Newswire Inc.ACCESS Newswire Reports Q3 2025 Revenue Increase and Year-to-Date Decline
Loar Holdings Inc.Loar Holdings Reports 22.4% Revenue Growth to $126.8 Million in Q3 2025
BioXcel Therapeutics, Inc.BioXcel Therapeutics Reports Decrease in Revenue and Increased Net Loss for Third Quarter 2025
Lifeway Foods, Inc.Lifeway Foods Reports 24% Revenue Growth to $57.1 Million in Latest Quarter
Silexion Therapeutics CorpSilexion Therapeutics Reports $7.5 Million Net Loss for Nine-Month Period Ending September 30, 2025
AParadise Acquisition Corp.A Paradise Acquisition Corp. Reports Net Income of $1.48M in Q3 2025
ATOSSA THERAPEUTICS, INC.Atossa Therapeutics Reports $23.8 Million Net Loss and Increased R&D Expenses for Nine Months Ended September 30, 2025
ASPAC II Acquisition Corp.A SPAC II Acquisition Corp. Reports Q2 2025 Net Loss of $17,335 Amid Leadership Changes
Aprea Therapeutics, Inc.Aprea Therapeutics Reports 99% Revenue Decline and $2.97 Million Net Loss in Q3 2025
Metagenomi Therapeutics, Inc.Metagenomi Reports Decrease in Collaboration Revenue and Increased Net Loss for Q3 2025
Graphene & Solar Technologies LtdGraphene & Solar Technologies Limited Reports Significant Losses and No Revenue for Quarter Ending June 30, 2025